Meningococcal ACWY and Pneumococcal Conjugate Vaccines for Adults (2027)

This opportunity seeks qualified suppliers to provide Meningococcal ACWY vaccine and Pneumococcal conjugate vaccine (PCV20) for adult populations and at-risk groups. The vaccines are needed for distribution and administration programs with implementation expected in 2027. Suppliers should be capable of meeting regulatory standards, ensuring product quality, managing cold chain logistics, and supporting vaccination campaign initiatives. Interested vendors must demonstrate experience in vaccine supply, distribution capabilities, and compliance with health authority requirements.